2026-01-07 - Analysis Report
Okay, here's a comprehensive analysis of Nike (NKE) based on the data provided:

**1) Return Rate Comparison and Alpha/Beta Analysis**

*   **Company Overview:** Nike Inc. designs, develops, markets, and sells athletic footwear, apparel, equipment, and accessories worldwide.
*   **Return Rate Comparison:**
    *   NKE Cumulative Return: -26.57%
    *   VOO (S&P 500) Cumulative Return: 91.00%
    *   Divergence: -117.6 (Relative Divergence: 5.7)
*   **Analysis:** Nike has significantly underperformed the S&P 500. The divergence of -117.6 indicates a substantial difference in cumulative returns, with a relative divergence of 5.7 suggesting the divergence is near the minimum historically.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta  | Cap(B)  |
|------------|--------|--------|---------|-------|---------|
| 2016-2018  | 11.0%  | 19.2%  | 7.0%    | 1.0   | 113.3   |
| 2017-2019  | 46.0%  | 19.2%  | 29.0%   | 1.1   | 154.9   |
| 2018-2020  | 41.0%  | 19.2%  | 20.0%   | 1.0   | 216.3   |
| 2019-2021  | 55.0%  | 17.4%  | 12.0%   | 1.0   | 254.8   |
| 2020-2022  | -12.0% | 43.4%  | -10.0%  | 1.1   | 178.9   |
| 2021-2023  | -27.0% | 43.4%  | -28.0%  | 1.2   | 166.0   |
| 2022-2024  | -67.0% | 37.8%  | -87.0%  | 1.2   | 115.7   |
| 2023-2025  | -55.0% | 44.0%  | -117.0% | 1.0   | 97.4    |

*   **CAGR:** The Compound Annual Growth Rate shows strong growth in earlier periods, but significant negative growth in recent periods.
*   **MDD:** The Maximum Drawdown indicates the maximum peak-to-trough decline during the period, reflecting significant volatility and risk.
*   **Alpha:** Alpha measures the stock's performance relative to the market. The negative Alpha values in recent periods indicate underperformance compared to the market.
*   **Beta:** Beta measures the stock's volatility relative to the market. A Beta around 1 suggests that NKE's volatility is similar to the market, while values greater than 1 indicate it's more volatile.
*   **Cap(B):** Market capitalization has decreased significantly, implying a loss of investor confidence.

**2) Recent Stock Price Fluctuations**

*   Current Price: 63.28
*   Last Market Price: 65.35 (Previous Close: 64.53, Change: 1.27)
*   5-day SMA: 62.06
*   20-day SMA: 63.46
*   60-day SMA: 64.57

**Analysis:** The current price is below the 20-day and 60-day SMAs, suggesting a short-term downtrend. The recent market price shows a slight increase, which may indicate a potential reversal or consolidation.

**3) RSI, PPO, and Expected Return**

*   Market Risk Indicator (MRI): 0.8 (Medium Investment Recommended)
*   RSI: 37.68
*   PPO: 0.068
*   Hybrid Signal: Buy 90% of cash (15 shares - Safe - MRI: 0.80) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   Recent (20 days) relative divergence change: 4.2 (+) (short-term increase)
*   Expected Return: -595.3%

**Analysis:**

*   **MRI:** The medium investment recommendation suggests a balanced risk profile.
*   **RSI:** The RSI of 37.68 indicates that the stock is approaching oversold conditions, which could signal a potential buying opportunity.
*   **PPO:** The PPO of 0.068 suggests a slightly positive momentum, but the overall trend needs to be considered.
*   **Hybrid Signal:** The recommendation to buy 90% of cash suggests the system identifies a buying opportunity.
*   **Divergence Change:** Recent increase in divergence indicates possible short-term upward movement.
*   **Expected Return:**  The extremely negative expected return suggests a highly pessimistic outlook for long-term investment.

**4) Recent News & Significant Events**

*   **Positive:** Insider buying (including Apple's CEO and Nike's CEO) could indicate confidence in the company's future. Articles suggest potential upside.
*   **Negative/Mixed:** One analyst lowered the price target.

**Analysis:** Recent news presents a mixed picture. Insider buying is generally a positive signal, suggesting confidence in the company's future. However, analyst downgrades temper the bullish sentiment.

**4-2) Analyst Opinions**

*   Consensus: Buy (~1.92)
*   Target Price (avg/high/low): 77.03 / 120.00 / 35.00
*   Recent Rating Changes: No rating changes provided.

**Analysis:** Analysts generally have a "Buy" rating on Nike, with an average target price of $77.03. However, the wide range of target prices (from $35 to $120) indicates significant uncertainty among analysts.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-10-01 | 0.49 | 11.72 B$    |
| 2025-04-03 | 0.54 | 11.27 B$    |
| 2025-01-03 | 0.78 | 12.35 B$    |
| 2024-10-07 | 0.7  | 11.59 B$    |
| 2025-10-01 | 0.7 | 11.59 B$ |
**Analysis:** EPS is lower than Q1 2025.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-11-30 | $12.43B | 40.60%        |
| 2025-08-31 | $11.72B | 42.18%        |
| 2025-05-31 | $11.10B | 40.27%        |
| 2025-02-28 | $11.27B | 41.49%        |
| 2024-11-30 | $12.35B | 43.62%        |

**Analysis:**  Revenue has fluctuated but remains relatively stable. Profit margins have seen some compression compared to the earlier period (2024-11-30).

**Capital and Profitability:**

| Quarter    | Equity  | ROE    |
|------------|---------|--------|
| 2025-11-30 | $14.09B | 5.62%  |
| 2025-08-31 | $13.47B | 5.40%  |
| 2025-05-31 | $13.21B | 1.60%  |
| 2025-02-28 | $14.01B | 5.67%  |
| 2024-11-30 | $14.04B | 8.29%  |

**Analysis:** Equity levels are relatively stable. ROE has decreased significantly from late 2024, indicating lower profitability relative to shareholder equity.

**7) Comprehensive Analysis (Summary)**

Nike is currently facing significant challenges, as evidenced by its underperformance compared to the S&P 500, negative Alpha, and declining ROE. While revenue remains relatively stable, profit margins have contracted. The negative expected return is concerning.

However, there are some potentially positive signals:

*   **Insider Buying:**  Suggests confidence from those closest to the company.
*   **RSI:** Approaching oversold territory could indicate a potential bounce.
*   **Analyst Consensus:**  Generally positive (Buy), but with wide-ranging price targets.

**Overall:** The data suggests a cautious approach to NKE. While potential buying opportunities may arise based on technical indicators and insider buying, the underlying financial performance and market sentiment warrant careful consideration and further investigation. The negative divergence and expected return cannot be ignored.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.